Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada.
Berman-Rosa M, Logan J, Ghazawi FM, Le M, Conte S, Netchiporouk E, Mukovozov IM, Cyr J, Mourad A, Miller WH, Claveau J, Salopek TG, Gniadecki R, Sasseville D, Rahme E, Lagacé F, Litvinov IV. Berman-Rosa M, et al. Among authors: miller wh. Dermatology. 2022;238(6):1006-1017. doi: 10.1159/000524949. Epub 2022 Jun 9. Dermatology. 2022. PMID: 35679838 Free PMC article.
Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients.
Zhou S, Sikorski D, Xu H, Zubarev A, Chergui M, Lagacé F, Miller WH Jr, Redpath M, Ghazal S, Butler MO, Petrella TM, Claveau J, Nessim C, Salopek TG, Gniadecki R, Litvinov IV. Zhou S, et al. Among authors: miller wh jr. Cancers (Basel). 2021 May 10;13(9):2282. doi: 10.3390/cancers13092282. Cancers (Basel). 2021. PMID: 34068774 Free PMC article. Review.
Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada.
Conte S, Ghazawi FM, Le M, Nedjar H, Alakel A, Lagacé F, Mukovozov IM, Cyr J, Mourad A, Miller WH Jr, Claveau J, Salopek TG, Netchiporouk E, Gniadecki R, Sasseville D, Rahme E, Litvinov IV. Conte S, et al. Among authors: miller wh jr. Front Med (Lausanne). 2022 Mar 3;9:830254. doi: 10.3389/fmed.2022.830254. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35308490 Free PMC article.
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.
Prabhu SA, Moussa O, Gonçalves C, LaPierre JH, Chou H, Huang F, Richard VR, Ferruzo PYM, Guettler EM, Soria-Bretones I, Kirby L, Gagnon N, Su J, Silvester J, Krisna SS, Rose AAN, Sheppard KE, Cescon DW, Mallette FA, Zahedi RP, Borchers CH, Del Rincon SV, Miller WH. Prabhu SA, et al. Among authors: miller wh. Mol Cancer Ther. 2023 Feb 1;22(2):192-204. doi: 10.1158/1535-7163.MCT-22-0092. Mol Cancer Ther. 2023. PMID: 36722142
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
D'Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, Savage KJ, Miller WH Jr, Mohr P, Marquez-Rodas I, Charles J, Kaatz M, Sznol M, Weber JS, Shoushtari AN, Ruisi M, Jiang J, Wolchok JD. D'Angelo SP, et al. Among authors: miller wh jr. J Clin Oncol. 2017 Jan 10;35(2):226-235. doi: 10.1200/JCO.2016.67.9258. Epub 2016 Nov 7. J Clin Oncol. 2017. PMID: 28056206 Free PMC article.
The role of eIF4E in response and acquired resistance to vemurafenib in melanoma.
Zhan Y, Dahabieh MS, Rajakumar A, Dobocan MC, M'Boutchou MN, Goncalves C, Lucy SL, Pettersson F, Topisirovic I, van Kempen L, Del Rincón SV, Miller WH Jr. Zhan Y, et al. Among authors: miller wh jr. J Invest Dermatol. 2015 May;135(5):1368-1376. doi: 10.1038/jid.2015.11. Epub 2015 Jan 23. J Invest Dermatol. 2015. PMID: 25615552 Free article.
657 results